(2017) 130(12):e527e9
Shaking the Vial Already covered, but worth repeating: shaking creates foam, and foam destroys peptide
Treatment with semaglutide significantly elevated plasma GLP-1 levels in both Bbs5 / and WT mice (Figure 6A), confirming that intervention was effective regardless of genotype
Publishers Note All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Berberine may cause gastrointestinal side effects (diarrhea, cramping), which can overlap with GLP-1-induced nausea or appetite changes, making symptom attribution complex
It describes them as typically mild to moderate and often resolving within days to weeks, and notes the experience is inconsistent: some patients report none at all while others get them only transiently